New dashboard aims to boost PrEP access and cut HIV disparities

NCT ID NCT07231640

Recruiting now Prevention Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new data dashboard to help clinics in Alabama track and improve how they provide PrEP, a daily pill that prevents HIV. The dashboard shows real-time data on PrEP prescriptions and patient needs, aiming to reduce racial gaps in HIV prevention. Researchers will work with 56 clinic staff across 7 sites to see if the tool helps more Black patients get PrEP.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PrOTECT AL Implementation Strategy (data dashboard and website)
What this could lead to: If successful, this could help clinics better identify and address gaps in PrEP services, potentially reducing HIV rates and racial disparities in Alabama.
What could go wrong: This is a small, early-stage implementation study with only 56 participants from 7 clinics, so results may not apply broadly. The dashboard's impact depends on how well clinics use it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

posterior leukoencephalopathy syndrome HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV HIV PREVENTION PREP PREP UPTAKE

Contacts and locations

Locations

University of Alabama at Birmingham
RECRUITING

Birmingham, Alabama, 35222, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.